✦ LIBER ✦

Phase II study of 4-epirubicin, etoposide and cisplatin as neoadjuvant chemotherapy in locally advanced breast cancer

✍ Scribed by Costa, M.A.; Lamarca, J.E.; Bader, G.R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of epirubicin, cisplati

✍ Kenneth Villman; John F. Öhd; Elisabet Lidbrink; Lena Malmberg; Birgitta Lindh; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Phase II study of docetaxel, capecitabin

✍ Yen-Shen Lu; Dar-Ren Chen; Ling-Min Tseng; Dah-Cherng Yeh; Shou-Tung Chen; Chia- 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Docetaxel and high-dose epirubicin as ne

✍ E. Espinosa; S. Morales; P. Borrega; A. Casas; C. Madroñal; I. Machengs; J. A. I 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

Phase II trial of paclitaxel and cisplat

✍ Tsuburaya, Akira; Nagata, Naoki; Cho, Haruhiko; Hirabayashi, Naoki; Kobayashi, M 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 206 KB

A prospective phase II study of topoteca

✍ N. Manci; C. Marchetti; C. Di Tucci; M. Giorgini; F. Esposito; I. Palaia; A. Mus 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Gemcitabine/Epirubicin/Paclitaxel as Neo

✍ John T. Hamm; John W. Wilson; Priya Rastogi; Barry C. Lembersky; George C. Tseng 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 114 KB